Lawyer Shares Outlook on DIR Fees and Reimbursement for Community Oncology Pharmacies in 2024
Jonathan Levitt, Esq, discusses legislation and legal action taken to rein in pharmacy benefit managers’ DIR fees.
Stay updated with breaking news from Jeff Mortier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jonathan Levitt, Esq, discusses legislation and legal action taken to rein in pharmacy benefit managers’ DIR fees.
This panel at the Community Oncology Alliance conference discussed the impact of PBM response to the end of direct and indirect remuneration (DIR) fees, which has been dramatic cuts to cancer drug reimbursement.
There is bipartisan support in the Congress for the Community Oncology Alliance's (COA) key agenda items, with hope that some will pass by year’s end.
Reps. Vern Buchanan (R-Fla.), Adrian Smith (R-Neb.) and Jason Smith (R-Mo.) have all thrown their hats in the ring to replace retiring Rep. Kevin Brady (R-Texas).